/ News, People

Blog with our Expert - Heinz Läubli

Meet Heinz Läubli from the Cancer Immunotherapy Laboratory at the Department of Biomedicine. One of his main research areas is the improvement of cancer immunotherapies. He is investigating the role of glycans and glycan-binding receptors in anti-cancer immunity and works on the improvement of immune checkpoint blockade and new cell therapies for solid cancers. Today he shares his research and vision for cancer immunotherapies.

Read the Blog